Mirae Asset Global Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125M Buy
495,003
+27,237
+6% +$5.86M 0.18% 77
2026
Q1
$102M Sell
467,766
-359,137
-43% -$79.7M 0.03% 62
2025
Q4
$189M Buy
826,903
+2,702
+0.3% +$616K 0.52% 28
2025
Q3
$191M Buy
824,201
+25,942
+3% +$5.28M 0.6% 22
2025
Q2
$148M Buy
798,259
+85,260
+12% +$15.8M 0.52% 36
2025
Q1
$145M Buy
712,999
+33,124
+5% +$6.44M 0.59% 30
2024
Q4
$119M Buy
679,875
+149,048
+28% +$27.4M 0.48% 33
2024
Q3
$102M Buy
530,827
+7,972
+2% +$1.49M 0.45% 39
2024
Q2
$87.2M Sell
522,855
-199,900
-28% -$33.1M 0.43% 41
2024
Q1
$123M Buy
722,755
+122,846
+20% +$21.2M 0.27% 66
2023
Q4
$93M Buy
599,909
+50,316
+9% +$7.34M 0.19% 118
2023
Q3
$81.9M Buy
549,593
+26,853
+5% +$3.94M 0.18% 125
2023
Q2
$70.4M Buy
522,740
+27,211
+5% +$3.99M 0.15% 145
2023
Q1
$79M Buy
495,529
+13,797
+3% +$2.11M 0.18% 115
2022
Q4
$77.9M Buy
481,732
+32,008
+7% +$4.91M 0.2% 114
2022
Q3
$60.4M Buy
449,724
+14,541
+3% +$2.09M 0.16% 136
2022
Q2
$66.7M Buy
435,183
+90,635
+26% +$13.8M 0.17% 131
2022
Q1
$55.9M Buy
344,548
+1,441
+0.4% +$209K 0.12% 194
2021
Q4
$46.5M Buy
343,107
+13,735
+4% +$1.62M 0.1% 240
2021
Q3
$35.5M Buy
329,372
+26,174
+9% +$2.99M 0.09% 264
2021
Q2
$34.2M Buy
303,198
+24,306
+9% +$2.74M 0.1% 264
2021
Q1
$30.2M Buy
278,892
+43,021
+18% +$4.6M 0.1% 255
2020
Q4
$25.3M Buy
235,871
+25,275
+12% +$2.43M 0.09% 258
2020
Q3
$18.4M Sell
210,596
-25,579
-11% -$2.41M 0.09% 260
2020
Q2
$23.2M Buy
236,175
+61,254
+35% +$5.39M 0.14% 168
2020
Q1
$13.3M Sell
174,921
-24,056
-12% -$2.05M 0.1% 214
2019
Q4
$17.6M Buy
198,977
+101,580
+104% +$8.43M 0.11% 224
2019
Q3
$7.38M Sell
97,397
-7,773
-7% -$533K 0.05% 386
2019
Q2
$7.62M Sell
105,170
-2,566
-2% -$202K 0.05% 368
2019
Q1
$8.68M Sell
107,736
-2,968
-3% -$243K 0.06% 295
2018
Q4
$10.2M Sell
110,704
-4,802
-4% -$422K 0.09% 227
2018
Q3
$10.9M Buy
115,506
+32,046
+38% +$3.04M 0.08% 245
2018
Q2
$7.73M Buy
83,460
+11,312
+16% +$1.1M 0.11% 132
2018
Q1
$6.83M Sell
72,148
-38,535
-35% -$4.23M 0.09% 145
2017
Q4
$10.7M Buy
110,683
+12,627
+13% +$1.19M 0.14% 105
2017
Q3
$8.71M Buy
98,056
+24,412
+33% +$1.86M 0.16% 113
2017
Q2
$5.34M Sell
73,644
-8,758
-11% -$589K 0.09% 143
2017
Q1
$5.37M Sell
82,402
-3,830
-4% -$241K 0.1% 134
2016
Q4
$5.4M Buy
86,232
+16,572
+24% +$1.01M 0.12% 133
2016
Q3
$4.39M Buy
69,660
+19,371
+39% +$1.25M 0.09% 153
2016
Q2
$3.11M Sell
50,289
-27,921
-36% -$1.7M 0.08% 174
2016
Q1
$4.47M Sell
78,210
-408,881
-84% -$22.8M 0.12% 127
2015
Q4
$28.9M Buy
487,091
+53,320
+12% +$3.07M 0.95% 25
2015
Q3
$23.6M Sell
433,771
-70,133
-14% -$4.57M 0.97% 25
2015
Q2
$33.9M Sell
503,904
-42,820
-8% -$2.8M 1.09% 26
2015
Q1
$32M Sell
546,724
-167,791
-23% -$10.1M 1.09% 29
2014
Q4
$46.8M Buy
714,515
+36,550
+5% +$2.3M 1.7% 14
2014
Q3
$39.2M Sell
677,965
-76,298
-10% -$4.24M 1.41% 26
2014
Q2
$42.6M Buy
754,263
+697,491
+1,229% +$36.6M 0.95% 33
2014
Q1
$2.92M Buy
56,772
+3,739
+7% +$189K 0.07% 98
2013
Q4
$2.8M Buy
+53,033
New +$2.61M 0.12% 106

Other funds holding ABBV

Mirae Asset Global Investments's ABBV Position: Q2 2026 in Review

Mirae Asset Global Investments increased its AbbVie (ABBV) stake by 5.8% in Q2 2026, buying an estimated $5.86M and bringing the position to 495,003 shares worth $125M. The position accounts for 0.18% of the portfolio, ranked #77.

Mirae Asset Global Investments first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $191M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mirae Asset Global Investments held 495,003 shares of AbbVie worth $125M as of Q2 2026.
  • Mirae Asset Global Investments bought 27,237 AbbVie shares in Q2 2026, an estimated $5.86M.
  • AbbVie made up 0.18% of Mirae Asset Global Investments's portfolio in Q2 2026, its #77 holding.
  • Mirae Asset Global Investments first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • Mirae Asset Global Investments's AbbVie position peaked at $191M in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.